HMGA2 and nasopharyngeal carcinoma: Studies have found (67) that HMGA2 is involved in the regulation of cisplatin resistance, and the expression level of HMGA2 in nasopharyngeal carcinoma cell lines is positively correlated with the degree of cisplatin resistance, and inhibiting the expression or function of HMGA2 can increase the sensitivity of cisplatin to nasopharyngeal carcinoma cells.